Abstract:ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations are rapidly emerging. In particular, beneficial mutations in the spike (S) protein, which can either make a person more infectious or enable immunological escape, are providing a significant obstacle to the prevention and treatment of pandemics. However, how the virus acquires a high number of beneficial mutations in a short time remains a mystery. We demonstrate here that variations of concern may be mutated due in part to the influence of the human microbiome. We searched the National Center for Biotechnology Information database for homologous fragments (HFs) after finding a mutation and the six neighboring amino acids in a viral mutation fragment. Among the approximate 8,000 HFs obtained, 61 mutations in S and other outer membrane proteins were found in bacteria, accounting for 62% of all mutation sources, which is 12-fold higher than the natural variable proportion. A significant proportion of these bacterial species—roughly 70%—come from the human microbiota, are mainly found in the lung or gut, and share a composition pattern with COVID-19 patients. Importantly, SARS-CoV-2 RNA-dependent RNA polymerase replicates corresponding bacterial mRNAs harboring mutations, producing chimeric RNAs. SARS-CoV-2 may collectively pick up mutations from the human microbiota that change the original virus’s binding sites or antigenic determinants. Our study clarifies the evolving mutational mechanisms of SARS-CoV-2. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations are rapidly emerging, in particular advantageous mutations in the spike (S) protein, which either increase transmissibility or lead to immune escape and are posing a major challenge to pandemic prevention and treatment. However, how the virus acquires a high number of advantageous mutations in a short time remains a mystery. Here, we provide evidence that the human microbiota is a reservoir of advantageous mutations and aids mutational evolution and host adaptation of SARS-CoV-2. Our findings demonstrate a conceptual breakthrough on the mutational evolution mechanisms of SARS-CoV-2 for human adaptation. SARS-CoV-2 may grab advantageous mutations from the widely existing microorganisms in the host, which is undoubtedly an “efficient” manner. Our study might open a new perspective to understand the evolution of virus mutation, which has enormous implications for comprehending the trajectory of the COVID-19 pandemic.

Chronic infections can generate SARS-CoV-2-like bursts of viral evolution without epistasis

Within-host evolution of SARS-CoV-2: how often are de novo mutations transmitted from symptomatic infections?

Diverse patterns of intra-host genetic diversity in chronically infected SARS-CoV-2 patients

SARS-CoV-2 evolution during prolonged infection in immunocompromised patients

Determinants of SARS-CoV-2 within-host evolutionary rates in persistently infected individuals

Patient-derived SARS-CoV-2 Mutations Impact Viral Replication Dynamics and Infectivity in Vitro and with Clinical Implications in Vivo

SARS-CoV-2 population dynamics in immunocompetent individuals in a closed transmission chain shows genomic diversity over the course of infection

Using big sequencing data to identify chronic SARS-Coronavirus-2 infections

Modeling Viral Evolution: A Novel SIRSVIDE Framework with Application to SARS-CoV-2 Dynamics

Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis

Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System

Intrahost dynamics, together with genetic and phenotypic effects predict the success of viral mutations

Rapid evolution of SARS-CoV-2 challenges human defenses

Intra-host evolution during SARS-CoV-2 prolonged infection

Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection

Eco-evolutionary dynamics of adapting pathogens and host immunity

Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants

The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations

Multiple possible patterns can emerge from virus-immune coevolution

Endogenous viral mutations, evolutionary selection, and containment policy design

Relatively Rapid Evolution Rates of SARS-CoV-2 Spike Gene at the Primary Stage of Massive Vaccination